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Insulin has previously been shown to attenuate vasoconstrictor responses to pressor agonists and accelerate vascular smooth muscle relaxation and vascular smooth muscle Ca 2+ efflux. To further determine the role of insulin in regulating vascular smooth muscle Ca 2+ , quiescent A7r5 cultured vascular smooth muscle cells and human vascular smooth muscle cells were incubated with or without 10~7 or 10~8 M insulin for 1 hour and then loaded with fura 2-AM; intracellular Ca 2 * responses to and rates of recovery from angiotensin II (200 nM) and arginine vasopressin (AVP) (10 /iM) were studied fluorometrically in stirred suspension. Insulin (10~7 M) caused an increase in the peak intracellular Ca 2 * response to angiotensin II (peak/baselinex 100=469+96 versus 288±74, P<.05) and a decrease in the peak Ca 2+ response to vasopressin (288±50 versus 389±33, P<.025). However, insulin also caused a marked increase in the rate of intracellular Ca 2+ recovery to baseline after stimulation with both angiotensin II (77.3±13. 8 We have suggested that vascular smooth muscle manifestations of insulin resistance, leading to loss of insulinmediated vasodilation, may be responsible for the hypertension in insulin-resistant states. 34 We have found insulin to attenuate in vitro vascular reactivity responses to vasoconstrictor agonists in endothelial-denuded aortic strips 34 and to accelerate endothelium-independent relaxation after vasoconstriction, whereas these effects are substantially lost in aortic strips from insulin-resistant (Zucker obese) rats. 4 Further, physiological concentrations of insulin were recently reported to inhibit angiotensin II (Ang II) and serotonin-induced contraction of canine femoral artery smooth muscle cells. blood flow during concomitant norepinephrine infusion in humans. 9 Moreover, Dubey et al 10 reported that treatment with pioglitazone, a thiazolidinedione compound that amplifies peripheral cellular responses to insulin, 11 resulted in attenuation of hypertension in both Dahl salt-sensitive and one-kidney, one clip hypertensive rats.
Insulin has been shown to decrease peak intracellular Ca 2+ ([Ca 2+ ],) responses to vasopressin in cultured rat aortic smooth muscle cells by reducing Ca 2+ influx through receptor-operated channels and to decrease voltage-mediated Ca 2+ influx. 12 Moreover, we have found insulin to increase the expression of both sarcoplasmic reticulum and plasma membrane Ca 2+ -ATPases 13 and to cause a corresponding increase in Ca 2+ efflux. 6 Accordingly, we conducted the present studies to further define the role of insulin in regulating vascular smooth muscle cell (VSMC) [Ca 2+ ], responses to vasoconstrictor agonists. We have studied the effects of insulin on Ang II and arginine vasopressin-induced [Ca 2+ ], transients, since Ang II-induced Ca 2+ transients are mediated by release from sarcoplasmic reticulum stores rather than transmembrane Ca 2+ flux and may therefore be regulated differently by insulin than is the vasopressin-induced [Ca 2+ ]j transient. We report herein that although insulin exerts markedly different effects on peak Ca 2+ responses to the two agonists, with response to Ang II augmented, insulin accelerates the rate of recovery from both agonists and reduces the area under the [Ca 2+ ]j response curve after stimulation with either agonist.
Methods

Vascular Smooth Muscle Cell Preparation
A clonal VSMC line (A7r5) from thoracic aorta of BD1X rats was obtained from American Type Culture Collection, Rockville, Md. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 10,000 U/mL penicillin, 10 mg/mL streptomycin, and 8 mg/mL tylosin tartrate and were maintained in a 5% CO 2 , 100% humidity atmosphere at 37°C. In a separate series of studies, human pulmonary artery VSMCs were obtained (Clonetics, Inc., San Diego, Calif.) in passage 3 and grown as described above in a medium containing 5% fetal calf serum, 10 ng/mL epidermal growth factor, 1 mM dexamethasone, 2 ng/mL human fibroblast growth factor, gentamicin, and amphotericin-B.
14 For sequential passage or study, confluent cells were rinsed with Ca 2+ / Mg 2+ -free Hanks' balanced salt solution (Sigma Chemical Co., St. Louis, Mo.) and treated with 0.5 mg/mL trypsin for 5 minutes at 37°C. Released cells were centrifuged at 750g for 5 minutes, and the pellet was then resuspended in DMEM. The growth medium of confluent cells was replaced with serum-free DMEM and antibiotics (as above) for 24 hours before VSMC Ca 2+ studies. A7r5 cells were studied in passages 4 to 22, and human cells were studied in passages 5 to 6.
Ca
2+ Determination
The fluorescent dye fura-2/AM (acetylmethoxy ester, Calbiochem, San Diego, Calif.) was dissolved in DMSO to yield a final fura-2 concentration of 10 /JM. Ang II, AVP, and digitonin were obtained from Sigma. Ang II and AVP were dissolved in serum-free HEPES-buffered salt solution (HBSS) containing (in mM): NaCl 138, CaCl 2 1.8, MgSO, 0.8, NaH 2 PO 4 0.9, NaHCO 3 4.0, D-glucose 25, glutamine 6.0, HEPES 20, and 5% bovine serum albumin, pH 7.4.
Confluent cell monolayers were maintained in serumfree DMEM for 24 hours, and quiescent cells were then rinsed with Hanks' solution, trypsinized, and centrifuged. The pellet was resuspended in HBSS, and cell suspensions were prechilled on ice for approximately 10 minutes before fura-2/AM loading. Fura-2-loaded cells were incubated in a shaking water bath in the dark for 20 minutes at 37°C and then sedimented by centrifugation and resuspended in HBSS. Cells were further incubated for 60 minutes in a 37°C shaking water bath with or without insulin (10~7 or 10" 8 M). Cells were then washed, centrifuged, and resuspended at a concentration of approximately 10 6 cells/mL. [Ca 2+ ], levels were then determined fluorometrically in suspensions using dual excitation (340 and 380 nm) per single emission (510 nm) fluorometry (Hitachi F-2000, Naperville, 111.).
Maximal and minimal fluorescent signals were obtained with 40 fiM digitonin and pH 8. was calculated from the slope of the [Ca 2+ ]i tracings in the recovery (ie, post-peak) phase. Recovery was calculated by regression analysis. All data were captured in a microcomputer using a data acquisition program, and data points were converted to a spreadsheet format (QUATTRO PRO 4.0, Borland International, Inc., Scotts Valley, Calif.). Regression analysis was performed on the first 30-second period after each peak response. The data were uniformly linear for at least 45 seconds in all cases. Attempts to fit the full recovery data set from each curve with an exponential regression resulted in qualitatively comparable data, but the exponential regressions resulted in a poorer fit (ie, larger error term).
All experiments were replicated eight times, and data were analyzed for differences between control and insulin-treated VSMCs using the unpaired / test.
Results
Baseline [Ca
2+
]i levels were not significantly affected by insulin incubation. Figs 1 and 2 ]j recovery to baseline in cultured VSMCs after stimulation with either Ang II or AVP. We have recently reported that insulin incubation also stimulates the expression of plasmalemma Ca 2+ -ATPase in A7r5 cultured VSMCs 13 and causes a corresponding increase in Ca 2+ -ATPase-mediated Ca 2+ efflux. We have also found insulin to increase the expression of sarcoplasmic reticulum (SR) Ca 2+ -ATPase in these cells, 13 although the time course of this stimulation was somewhat delayed in comparison with stimulation of the plasmalemma Ca 2+ -ATPase. Accordingly, the increase in [Ca 2+ ], recovery rate in the present study probably reflects insulin stimulation of plasmalemma Ca 2+ -ATPase, SR Ca 2+ -ATPase, or both.
In support of this concept, we have previously reported that insulin stimulates rat aortic 45 Ca 2+ efflux in a dose-dependent fashion. 6 Moreover, we have also recently reported decreases in both plasmalemma Ca 2+ -ATPase expression 16 and the rate of [Ca 2+ ], return to baseline in VSMCs obtained from Zucker obese rat aortas compared with Zucker lean rat aortas. 17 Since the Zucker obese rat exhibits insulin resistance, we conclude that these observations result from a vascular smooth muscle manifestation of insulin resistance and a consequent failure of insulin to stimulate Ca 2+ -ATPase expression and Ca 2+ efflux.
Insulin attenuation of vasoconstrictor responses may also result, in part, from blunting of the peak [Ca 2+ ]j response to vasoconstrictor agonists. Insulin has been shown to decrease peak [Ca 2+ ], responses to AVP in cultured rat aortic smooth muscle cells by reducing Ca 2+ influx through receptor-operated channels and to decrease voltage-mediated Ca 2+ influx. 12 Results of the present study are consistent with these observations since insulin incubation resulted in a significant reduction in the peak [Ca 2+ ], response to AVP in A7r5 VSMCs. However, the physiological significance of this observation is not clear because we found no difference in the peak [Ca 2+ ]; response to AVP in VSMCs isolated from Zucker lean and obese rats. 17 Thus, despite other vascular smooth muscle manifestations of insulin resistance in Zucker obese rats, insulin regulation of AVP receptor-operated vascular smooth muscle Ca 2+ channels appears to be preserved in this model of insulin resistance. Moreover, insulin attenuation of the peak [Ca 2+ ]j response was not evident in human VSMCs in the present study. whereas these effects are blunted in vascular smooth muscle from insulin-resistant animals. 4 Moreover, insulin infusion increases forearm blood flow 9 and reduces peripheral vascular resistance and blood pressure in both normotensive and hypertensive individuals. 7 - 8 Additional recent data also support the concept that elevated circulating insulin per se does not result in blood pressure elevations and that VSMC resistance to the actions of insulin may instead be responsible for hypertension in insulin-resistant states.
18 " 20 For example, Gans et al 18 recently reported that induction of acute hyperinsulinemia in a euglycemic clamp study of non-insulin-dependent diabetic patients resulted in blood pressure reductions despite observed reductions in the fractional excretion of sodium. Data from the present study, demonstrating an acceleration in [Ca 2+ ]j recovery rate after stimulation with vasoconstrictor agonists, appear to provide a physiological rationale for these observations.
